UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 58

Sortiert nach

Evaluating eligibility criteria of oncology trials using real-world data and AI

Nature (London), 2021-04, Vol.592 (7855), p.629-633

2021

Volltextzugriff (PDF)

Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer

American journal of obstetrics and gynecology, 2021-02, Vol.224 (2), p.191.e1-191.e15

2021

Volltextzugriff (PDF)

Overall survival in patients with advanced non-small cell lung cancer with KRAS G12C mutation with or without STK11 and/or KEAP1 mutations in a real-world setting

BMC cancer, 2023-04, Vol.23 (1), p.352-352, Article 352

2023

Volltextzugriff (PDF)

Replication of Overall Survival, Progression-Free Survival, and Overall Response in Chemotherapy Arms of Non-Small Cell Lung Cancer Trials Using Real-World Data

Clinical cancer research, 2022-07, Vol.28 (13), p.2844-2853

2022

Volltextzugriff (PDF)

Applying the estimand and target trial frameworks to external control analyses using observational data: a case study in the solid tumor setting

Frontiers in pharmacology, 2024, Vol.15, p.1223858-1223858

2024

Volltextzugriff (PDF)

Factors prognostic of survival in advanced-stage uterine serous carcinoma

Gynecologic oncology, 2017-07, Vol.146 (1), p.27-33

2017

Volltextzugriff (PDF)

Real-World Comparative Effectiveness of First-Line Alectinib Versus Crizotinib in Patients With Advanced ALK-Positive NSCLC With or Without Baseline Central Nervous System Metastases

JTO clinical and research reports, 2023-04, Vol.4 (4), p.100483-100483, Article 100483

2023

Volltextzugriff (PDF)

Predictors of long-term response in prospective phase II trial of levonorgestrel intrauterine device for atypical hyperplasia and early endometrial cancer (1247)

Gynecologic oncology, 2023-09, Vol.176, p.S157-S157

2023

Volltextzugriff (PDF)

Treatment of Low-Risk Endometrial Cancer and Complex Atypical Hyperplasia With the Levonorgestrel-Releasing Intrauterine Device

Obstetrics and gynecology (New York. 1953), 2018-01, Vol.131 (1), p.109-116

2018

Volltextzugriff (PDF)

Systematic pan-cancer analysis of mutation–treatment interactions using large real-world clinicogenomics data

Nature medicine, 2022-08, Vol.28 (8), p.1656-1661

2022

Volltextzugriff (PDF)

Abstract 660: Real-world prevalence of metastasis and overall survival (OS) in patients with advanced non-small cell lung cancer (aNSCLC) with KRAS G12C and with or without STK11 or KEAP1 mutations

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.660-660

2021

Volltextzugriff (PDF)

Abstract PO034: Long-term follow-up for a prospective phase II trial of levonorgestrel intrauterine device as non-surgical treatment for complex atypical hyperplasia and early endometrial cancer

Clinical cancer research, 2021-02, Vol.27 (3_Supplement), p.PO034-PO034

2021

Volltextzugriff (PDF)

Disparities in oncofertility referral, treatment utilization, and fertility outcomes among women with atypical hyperplasia or early endometrioid endometrial cancer treated with the levonorgestrel intrauterine device (2228)

Gynecologic oncology, 2023-09, Vol.176, p.S273-S274

2023

Volltextzugriff (PDF)

Identifying prognostic and predictive value of mutations associated with clinical outcomes in first line (1L) patients with advanced or metastatic non–small cell lung cancer (aNSCLC)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.9047-9047

2022

Volltextzugriff (PDF)

Does adding claims to EMR data improve comorbidity burden capture? A Concerto Health AI Definitive Oncology Dataset and Symphony Linkage Study

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e18186-e18186

2019

Volltextzugriff (PDF)

Overall survival after pelvic exenteration for gynecologic malignancy

Gynecologic oncology, 2014-09, Vol.134 (3), p.546-551

2014

Volltextzugriff (PDF)

Machine Learning Prediction of Clinical Trial Operational Efficiency

The AAPS journal, 2022-05, Vol.24 (3), p.57-57, Article 57

2022

Volltextzugriff (PDF)

Sa1416 Differences in ERCP Related Practice Patterns - an Electronic Survey

Gastrointestinal endoscopy, 2015-05, Vol.81 (5), p.AB205-AB206

2015

Volltextzugriff (PDF)

Identification of non-actionable mutations with prognostic and predictive value in patients with advanced or metastatic non-small cell lung cancer

Clinical & translational oncology, 2024-06, Vol.26 (6), p.1384-1394

2024

Volltextzugriff (PDF)

Prospective Phase II Trial of Levonorgestrel Intrauterine Device: Non-Surgical Approach for Complex Atypical Hyperplasia and Early Endometrial Cancer

American journal of obstetrics and gynecology, 2020-08, Vol.224 (2), p.191.e1-191.e15

2020

Volltextzugriff (PDF)

Systematic analysis of off-label and off-guideline cancer therapy usage in a real-world cohort of 165,912 US patients

Cell reports. Medicine, 2024-03, Vol.5 (3), p.101444-101444, Article 101444

2024

Volltextzugriff (PDF)

PTEN loss is a context-dependent outcome determinant in obese and non-obese endometrioid endometrial cancer patients

Molecular oncology, 2015-10, Vol.9 (8), p.1694-1703

2015

Volltextzugriff (PDF)

Phase I trial of paclitaxel, bevacizumab, and temsirolimus in advanced solid malignancies

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.2573-2573

2016

Volltextzugriff (PDF)

Factors prognostic of survival in advanced stage uterine papillary serous carcinoma

Pal, Navdeep

2015

Volltextzugriff (PDF)

Pathologic distribution of disease at the time of interval debulking versus primary tumor reduction in women with primary peritoneal, ovarian, or Fallopian tube carcinoma

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.5584-5584

2013

Volltextzugriff (PDF)

1 – 25 von 58

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(50)

Publikationsform

Sprache

Englisch
(58)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(32)
Life Sciences & Biomedicine
(21)
Humans
(14)
Oncology
(12)
Female
(8)
Materials Science
(7)
Physical Sciences
(7)
Technology
(7)
Middle Aged
(6)
Adult
(5)
Chemistry
(5)
Engineering
(5)
Materials Science, Multidisciplinary
(5)
Physics
(5)
Prognosis
(5)
Aged
(4)
Aged, 80 And Over
(4)
Cancer
(4)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(4)
Lung Neoplasms - Drug Therapy
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Evaluating eligibility criteria of oncology trials using real-world data and AI

Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer

Overall survival in patients with advanced non-small cell lung cancer with KRAS G12C mutation with or without STK11 and/or KEAP1 mutations in a real-world setting

Replication of Overall Survival, Progression-Free Survival, and Overall Response in Chemotherapy Arms of Non-Small Cell Lung Cancer Trials Using Real-World Data

Applying the estimand and target trial frameworks to external control analyses using observational data: a case study in the solid tumor setting

Factors prognostic of survival in advanced-stage uterine serous carcinoma

Real-World Comparative Effectiveness of First-Line Alectinib Versus Crizotinib in Patients With Advanced ALK-Positive NSCLC With or Without Baseline Central Nervous System Metastases

Predictors of long-term response in prospective phase II trial of levonorgestrel intrauterine device for atypical hyperplasia and early endometrial cancer (1247)

Treatment of Low-Risk Endometrial Cancer and Complex Atypical Hyperplasia With the Levonorgestrel-Releasing Intrauterine Device

Systematic pan-cancer analysis of mutation–treatment interactions using large real-world clinicogenomics data

Abstract 660: Real-world prevalence of metastasis and overall survival (OS) in patients with advanced non-small cell lung cancer (aNSCLC) with KRAS G12C and with or without STK11 or KEAP1 mutations

Abstract PO034: Long-term follow-up for a prospective phase II trial of levonorgestrel intrauterine device as non-surgical treatment for complex atypical hyperplasia and early endometrial cancer

Disparities in oncofertility referral, treatment utilization, and fertility outcomes among women with atypical hyperplasia or early endometrioid endometrial cancer treated with the levonorgestrel intrauterine device (2228)

Identifying prognostic and predictive value of mutations associated with clinical outcomes in first line (1L) patients with advanced or metastatic non–small cell lung cancer (aNSCLC)

Does adding claims to EMR data improve comorbidity burden capture? A Concerto Health AI Definitive Oncology Dataset and Symphony Linkage Study

Overall survival after pelvic exenteration for gynecologic malignancy

Machine Learning Prediction of Clinical Trial Operational Efficiency

Sa1416 Differences in ERCP Related Practice Patterns - an Electronic Survey

Identification of non-actionable mutations with prognostic and predictive value in patients with advanced or metastatic non-small cell lung cancer

Prospective Phase II Trial of Levonorgestrel Intrauterine Device: Non-Surgical Approach for Complex Atypical Hyperplasia and Early Endometrial Cancer

Systematic analysis of off-label and off-guideline cancer therapy usage in a real-world cohort of 165,912 US patients

PTEN loss is a context-dependent outcome determinant in obese and non-obese endometrioid endometrial cancer patients

Phase I trial of paclitaxel, bevacizumab, and temsirolimus in advanced solid malignancies

Factors prognostic of survival in advanced stage uterine papillary serous carcinoma

Pathologic distribution of disease at the time of interval debulking versus primary tumor reduction in women with primary peritoneal, ovarian, or Fallopian tube carcinoma

Suchergebnisse filtern